Literature DB >> 10701265

Quantification and rapid metabolite identification in drug discovery using API time-of-flight LC/MS.

N Zhang1, S T Fountain, H Bi, D T Rossi.   

Abstract

Liquid chromatography/mass spectrometry (LC/MS), utilizing a time-of-flight (TOF) mass analyzer, has been evaluated and applied to problems in bioanalysis for pharmacokinetics and drug metabolism. The data obtained by TOF MS differ from those obtained using quadrupole mass spectrometer instruments in that full-scan spectra can be routinely collected with greater sensitivity and speed. Both quantitative and qualitative information, including compound concentration in rat plasma and full-scan atmospheric pressure ionization mass spectra, are concurrently obtained. This approach has been used to characterize the disposition of several drug compounds that have been simultaneously dosed to rats in a cassette format. Quantitation limits in the 5-25 ng/mL range (approximately 20 nM) were obtained from nominal mass chromatograms (0.5 Da resolution). A reference lock mass was used to provide accurate mass measurement to reach third decimal place accuracy in the monoisotopic molecular weight. An improvement in quantitation limits was demonstrated after using accurate mass determinations. Several possible preliminary drug metabolites were confirmed or refuted, based on accurate mass. The trend of metabolite formation and clearance was qualitatively evaluated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701265     DOI: 10.1021/ac9911701

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  12 in total

1.  Determination of the collisionally activated dissociation of a substituted indole by orthogonal acceleration quadrupole time-of-flight mass spectrometry.

Authors:  A P Watt; A Pike; D Morrison
Journal:  J Am Soc Mass Spectrom       Date:  2001-11       Impact factor: 3.109

Review 2.  Mass spectrometry innovations in drug discovery and development.

Authors:  D I Papac; Z Shahrokh
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

3.  Correction of accurate mass measurement for target compound verification by quadrupole time-of-flight mass spectrometry.

Authors:  Harald C Köfeler; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2005-03       Impact factor: 3.109

4.  Duty cycle enhancement of an orthogonal acceleration TOF mass spectrometer using an axially-resonant excitation linear ion trap.

Authors:  Yuichiro Hashimoto; Hideki Hasegawa; Hiroyuki Satake; Takashi Baba; Izumi Waki
Journal:  J Am Soc Mass Spectrom       Date:  2006-08-22       Impact factor: 3.109

Review 5.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

6.  Quantitative-qualitative data acquisition using a benchtop Orbitrap mass spectrometer.

Authors:  Kevin P Bateman; Markus Kellmann; Helmut Muenster; Robert Papp; Lester Taylor
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-06       Impact factor: 3.109

Review 7.  Drug metabolite profiling and identification by high-resolution mass spectrometry.

Authors:  Mingshe Zhu; Haiying Zhang; W Griffith Humphreys
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

8.  Effects of ground loop currents on signal intensities in electrospray mass spectrometry.

Authors:  Richard A Ochran; Lars Konermann
Journal:  J Am Soc Mass Spectrom       Date:  2004-12       Impact factor: 3.109

9.  Rapid LC-MS drug metabolite profiling using microsomal enzyme bioreactors in a parallel processing format.

Authors:  Besnik Bajrami; Linlin Zhao; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2009-12-15       Impact factor: 6.986

Review 10.  Mass spectrometry techniques in the survey of steroid metabolites as potential disease biomarkers: a review.

Authors:  Maria João Gouveia; Paul J Brindley; Lúcio Lara Santos; José Manuel Correia da Costa; Paula Gomes; Nuno Vale
Journal:  Metabolism       Date:  2013-05-07       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.